ACT to Reduce Morbidity and Mortality in Hematopoietic Stem Cell Transplant Patients

This study is a phase 2, multicenter, randomized controlled trial to test the application of Acceptance and Commitment Therapy (ACT) in HCT patients. ACT is an evidence-based cognitive behavioral therapy intervention that emphasizes psychological flexibility and behaviors, helping transplant patients focus on actions that may help maintain adequate physical activity despite physical and emotional discomfort.

NCT Number	NCT07516314
Lead Sponsor	Anthony Sung, MD
Conditions	Stem Cell Transplant Patients
Enrollment	476 participants
Start Date	2026-05
Primary Completion	2030-01 (estimated)
Study Completion	2031-04 (estimated)
Updated on ClinicalTrials.gov	2026-04-07